A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes
Clinical trial NCT01951235 · COMPLETED
Trial details
- NCT number
- NCT01951235
- Sponsor
- Poxel SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-07-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.